Literature DB >> 20651743

Pain market.

Irena Melnikova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20651743     DOI： 10.1038/nrd3226

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  A difficult balance--pain management, drug safety, and the FDA.

Authors:  Janet Woodcock
Journal:  N Engl J Med       Date:  2009-11-26       Impact factor: 91.245

Review 2.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

Review 3.  Strategies for managing fibromyalgia.

Authors:  Lesley M Arnold
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965
  3 in total
  35 in total

Review 1.  Tetracyclines and pain.

Authors:  Leandro F S Bastos; Antônio C P de Oliveira; Linda R Watkins; Márcio F D Moraes; Márcio M Coelho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-27       Impact factor: 3.000

Review 2.  Drug repositioning: playing dirty to kill pain.

Authors:  Leandro Francisco Silva Bastos; Márcio Matos Coelho
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 3.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

Review 4.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

5.  Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias.

Authors:  Nicole M Kennedy; Cullen L Schmid; Nicolette C Ross; Kimberly M Lovell; Zhizhou Yue; Yen Ting Chen; Michael D Cameron; Laura M Bohn; Thomas D Bannister
Journal:  J Med Chem       Date:  2018-09-24       Impact factor: 7.446

Review 6.  Lost but making progress--Where will new analgesic drugs come from?

Authors:  David Borsook; Richard Hargreaves; Chas Bountra; Frank Porreca
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

7.  Anti-superoxide and anti-peroxynitrite strategies in pain suppression.

Authors:  Kali Janes; William L Neumann; Daniela Salvemini
Journal:  Biochim Biophys Acta       Date:  2011-12-19

8.  Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics.

Authors:  Cullen L Schmid; Nicole M Kennedy; Nicolette C Ross; Kimberly M Lovell; Zhizhou Yue; Jenny Morgenweck; Michael D Cameron; Thomas D Bannister; Laura M Bohn
Journal:  Cell       Date:  2017-11-16       Impact factor: 41.582

9.  Commonly used excipients modulate UDP-glucuronosyltransferase 2b7 activity to improve nalbuphine oral bioavailability in humans.

Authors:  Hong-Jaan Wang; Cheng-Huei Hsiong; Shung-Tai Ho; Min-Jen Lin; Tung-Yuan Shih; Pei-Wei Huang; Oliver Yoa-Pu Hu
Journal:  Pharm Res       Date:  2014-02-14       Impact factor: 4.200

Review 10.  Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.

Authors:  N T Burford; J R Traynor; A Alt
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.